Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Changes at Advanced Research Technologies:

This article was originally published in Clinica

Executive Summary

Quebec-based Canadian optical molecular imaging products company Advanced Research Technologies (ART) has promoted its vice-president, Sebastien Gignac to president, CEO and a member of the board of directors. He replaces, in all these roles, Micheline Bouchard, who has resigned, after achieving her goal of taking ART's products to the commercialisation stage, the company told Clinica. Mr Gignac, who is also the firm's corporate secretary and general counsel, joined the firm in 1998, prior to which he was an attorney specialising in business law for early development stage biotech and IT firms.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052438

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel